Diversity of the Origin of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Its Clinical Implications

被引:14
作者
Fukumoto, Chonji [1 ]
Uchida, Daisuke [2 ]
Kawamata, Hitoshi [1 ]
机构
[1] Dokkyo Med Univ, Sch Med, Dept Oral & Maxillofacial Surg, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan
[2] Ehime Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, 454 Shitsukawa, Toon, Ehime 7910295, Japan
关键词
oral squamous cell carcinoma; origin of cancer; stem cell; cancer stem cell; somatic stem cell; oral epithelial stem cell; bone marrow-derived stem cell; ACUTE MYELOID-LEUKEMIA; NECK NODE METASTASIS; BONE-MARROW; THERAPEUTIC IMPLICATIONS; MORPHOLOGICAL FEATURES; BIOLOGICAL MARKERS; DISTANT METASTASIS; GROWTH-FACTOR; RISK-FACTORS; HEAD;
D O I
10.3390/cancers14153588
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Oral squamous cell carcinoma (OSCC) histopathologically accounts for >= 90% of oral cancer. In this review article, we focus on the diversity of the origin of OSCC and also discuss cancer stem cells (CSCs). CSCs are a subset of cancer cells that occupy a very small portion of the cancer mass and have characteristics of stem cells. When gene abnormalities accumulate in somatic stem cells, those cells transform into CSCs. CSCs as the origin of cancer then autonomously grow and develop into cancer. The histopathological phenotype of cancer cells is determined by the original characteristics of the somatic stem cells and/or surrounding environment. OSCC may be divided into the following three categories with different malignancy based on the origin of CSCs: cancer from oral epithelial stem cell-derived CSCs, cancer from stem cells in salivary gland-derived CSCs, and cancer from bone marrow-derived stem cell-derived CSCs. Oral squamous cell carcinoma (OSCC) histopathologically accounts for >= 90% of oral cancer. Many clinicopathological risk factors for OSCC have also been proposed, and postoperative therapy is recommended in guidelines based on cancer stage and other risk factors. However, even if the standard treatment is provided according to the guidelines, a few cases rapidly recur or show cervical and distant metastasis. In this review article, we focus on the diversity of the origin of OSCC. We also discuss cancer stem cells (CSCs) as a key player to explain the malignancy of OSCC. CSCs are a subset of cancer cells that occupy a very small portion of the cancer mass and have characteristics of stem cells. When gene abnormalities accumulate in somatic stem cells, those cells transform into CSCs. CSCs as the origin of cancer then autonomously grow and develop into cancer. The histopathological phenotype of cancer cells is determined by the original characteristics of the somatic stem cells and/or surrounding environment. OSCC may be divided into the following three categories with different malignancy based on the origin of CSCs: cancer from oral epithelial stem cell-derived CSCs, cancer from stem cells in salivary gland-derived CSCs, and cancer from bone marrow-derived stem cell-derived CSCs.
引用
收藏
页数:12
相关论文
共 83 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]  
ALADIB W, 1990, CANCER RES, V50, P7650
[3]   Cell differentiation - Hepatocytes from nonhepatic adult stem cells [J].
Alison, MR ;
Poulsom, R ;
Jeffery, R ;
Dhillon, AP ;
Quaglia, A ;
Jacob, J ;
Novelli, M ;
Prentice, G ;
Williamson, J ;
Wright, NA .
NATURE, 2000, 406 (6793) :257-257
[4]   Improvement in Survival of Patients With Oral Cavity Squamous Cell Carcinoma [J].
Amit, Moran ;
Yen, Tzu-Chen ;
Liao, Chun-Ta ;
Chaturvedi, Pankaj ;
Agarwal, Jai Prakash ;
Kowalski, Luiz P. ;
Ebrahimi, Ardalan ;
Clark, Jonathan R. ;
Kreppel, Matthias ;
Zoeller, Joachim ;
Fridman, Eran ;
Bolzoni, Villaret A. ;
Shah, Jatin P. ;
Binenbaum, Yoav ;
Patel, Snehal G. ;
Gil, Ziv .
CANCER, 2013, 119 (24) :4242-4248
[5]  
[Anonymous], NCCN guidelines-head and neck cancers (Version 2.2023)
[6]   A solid tumor of donor cell-origin after allogeneic peripheral blood stem cell transplantation [J].
Arai, Y. ;
Arai, H. ;
Aoyagi, A. ;
Yamagata, T. ;
Mitani, K. ;
Kubota, K. ;
Kawamata, H. ;
Imai, Y. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) :3042-3043
[7]  
AZUMA M, 1989, CANCER RES, V49, P5435
[8]  
AZUMA M, 1988, CANCER RES, V48, P2898
[9]  
AZUMA M, 1986, CANCER RES, V46, P770
[10]  
AZUMA M, 1988, CANCER RES, V48, P7219